Literature DB >> 637206

Prognosis of undifferentiated carcinoma and lymphoma of the thyroid.

R Rossi, B Cady, W A Meissner, C E Sedgwick, J Werber.   

Abstract

Entities:  

Mesh：

Year:  1978        PMID： 637206     DOI： 10.1016/0002-9610(78)90042-9

Source DB:  PubMed          Journal:  Am J Surg        ISSN： 0002-9610            Impact factor:   2.565


× No keyword cloud information.
  7 in total

Review 1.  Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.

Authors:  Eleonora Molinaro; Cristina Romei; Agnese Biagini; Elena Sabini; Laura Agate; Salvatore Mazzeo; Gabriele Materazzi; Stefano Sellari-Franceschini; Alessandro Ribechini; Liborio Torregrossa; Fulvio Basolo; Paolo Vitti; Rossella Elisei
Journal:  Nat Rev Endocrinol       Date:  2017-07-14       Impact factor: 43.330

2.  Lymphoid and epithelial markers in small cell anaplastic thyroid tumours.

Authors:  A D Burt; D J Kerr; I L Brown; P Boyle
Journal:  J Clin Pathol       Date:  1985-08       Impact factor: 3.411

3.  Immunohistochemical reclassification of anaplastic carcinoma reveals small and giant cell lymphoma.

Authors:  T Hölting; P Möller; C Tschahargane; H Meybier; H Buhr; C Herfarth
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

4.  Response of undifferentiated thyroid carcinoma to combined modality treatment. Invited commentary.

Authors:  M A Block
Journal:  World J Surg       Date:  1979-08-31       Impact factor: 3.352

5.  Primary lymphoma of the thyroid: A review of the Mayo Clinic experience through 1978.

Authors:  R M Devine; A J Edis; P M Banks
Journal:  World J Surg       Date:  1981-01       Impact factor: 3.352

6.  Management of tracheal obstruction from thyroid diseases.

Authors:  B Cady
Journal:  World J Surg       Date:  1982-11       Impact factor: 3.352

Review 7.  Airway management, symptom relief and best supportive care in anaplastic thyroid cancer.

Authors:  Kelly F Moyer; Andrea R Marcadis; Ashok R Shaha
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2020-04       Impact factor: 1.814
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.